Resmed (RMD) Amortization of Deferred Charges (2021 - 2026)

Resmed's Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $10.1 million for Q1 2026.

• Quarterly Amortization of Deferred Charges rose 22.05% year-over-year to $10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.1 million (up 14.23% YoY) and the FY2025 annual result came in at $37.3 million, down 5.09% from the prior year.
• Amortization of Deferred Charges was $10.1 million for Q1 2026 at Resmed, down from $12.4 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $12.4 million in Q4 2025 and bottomed at $7.6 million in Q2 2022.
• A 5-year average of $9.3 million and a median of $9.0 million in 2024 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2024 — Amortization of Deferred Charges jumped 32.42% — and 2025, when it decreased 26.26%.
• Resmed's Amortization of Deferred Charges stood at $7.8 million in 2022, then rose by 10.47% to $8.6 million in 2023, then climbed by 10.21% to $9.5 million in 2024, then soared by 31.51% to $12.4 million in 2025, then decreased by 19.24% to $10.1 million in 2026.
• Business Quant data shows RMD's Amortization of Deferred Charges at $10.1 million in Q1 2026, $12.4 million in Q4 2025, and $10.0 million in Q3 2025.